Sunesis Pharmaceuticals, Inc. to Host Conference Call on June 6th to Discuss Corporate Updates and VALOR Poster Presented at American Society of Clinical Oncology 2011

SOUTH SAN FRANCISCO, Calif., May 26, 2011 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Monday June 6, 2011 at 9:00 a.m. Eastern Time to discuss the progress of the VALOR trial, provide a general corporate update, and review the VALOR adaptive design poster scheduled to be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL.